Status:
COMPLETED
Effect of Extra Virgin Olive Oil on Postprandial Blood Glucose in Type 2 Diabetes Mellitus Patients
Lead Sponsor:
Makati Medical Center
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
30-65 years
Phase:
NA
Brief Summary
Extra virgin olive oil (EVOO) is known for its cardiovascular effects and its effect on glucose lowering. However, the effects of EVOO on the blood glucose of Type 2 Diabetes Mellitus Filipino patient...
Detailed Description
During their first visit, the participants were oriented on the conduct of the study. They were advised to be compliant with their medications throughout the duration of the trial. On their second vi...
Eligibility Criteria
Inclusion
- patients aged 30-65 years old
- diagnosed with Type 2 Diabetes Mellitus
- body mass index under the overweight or obese class I category (by Asia Pacific guidelines)
Exclusion
- pregnant patients
- patients with history of frequent hypoglycemic episodes
- those at high risk of developing ketoacidosis and hyperglycemic hyperosmolar syndrome
- those with identified acute stress during the study (illness, fever, trauma leading to hospitalization)
- current intake of steroids
- olive oil allergy or intolerance
- digestive disorders
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2018
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04077216
Start Date
September 1 2018
End Date
November 30 2018
Last Update
September 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Makati Medical Center
Makati City, NCR, Philippines, 1004